英文别名:
[2,2'-Bimorphinan]-3,3',14,14'-tetrol,17,17'-bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-6,6'-bis(methylene)-, (5a)-(5'a)- (9CI);[2,2'-Bimorphinan]-3,3',14,14'-tetrol,17,17'-bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-6,6'-bis...;2,2'- Bisnalmefene;2,2?-Bisnalmefene (Nalmefene Impurity);2,2'-Bisnalmefene (Nalmefene Impurity);(5a)-(5'a)-17,17'-Bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-6,6'-bis(methylene)-[2,2'-bimorphinan]-3,3',14,14'-tetrol;(5alpha)-17-(cyclopropylmethyl)-2-[(5alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-6-methylidene-4,5-epoxymorphinan-2-yl]-6-methylidene-4,5-epoxymorphinan-3,14-diol;Nalmefene Impurity;Nalmefene Impurity A;NalMefene related substance;NalMefene Hydrochloride diMer;(5α)-(5'α)-17,17'-Bis(cyclopropylMethyl)-4,5:4',5'-diepoxy-6,6'-bis(Methylene)-[2,2'-biMorphinan]-3,3',14,14'-tetrol;2,2'-Bisnalmefene;2,2'-Bis(6-deoxo-6-methylenenaltrexone;2,2'-BisnalMefene (NalMefene IMpurity) (>85%);(4R,4aS,7aS,12bS)-10-[(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-10-yl]-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;2,2'-Bis(6-deoxo-6-methylenenaltrexone);17-(Cyclopropylmethyl)-2-[17-(cyclopropylmethyl)-3,14-dihydroxy-6-methylidene-4,5-epoxymorphinan-2-yl]-6-methylidene-4,5-epoxymorphinan-3,14-diol;F19374;DTXSID40938772;176220-84-1;2,2'-Bisnalmefene (>85%);(2,2'-Bimorphinan)-3,3',14,14'-tetrol, 17,17'-bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-6,6'-bis(methylene)-, (5alpha)-(5'alpha)-;
Inchi:
1S/C42H48N2O6/c1-21-7-9-41(47)29-17-25-15-27(33(45)35-31(25)39(41,37(21)49-35)11-13-43(29)19-23-3-4-23)28-16-26-18-30-42(48)10-8-22(2)38-40(42,32(26)36(50-38)34(28)46)12-14-44(30)20-24-5-6-24/h15-16,23-24,29-30,37-38,45-48H,1-14,17-20H2/t29-,30-,37+,38+,39+,40+,41-,42-/m1/s1